Breckenridge Pharmaceutical, Inc 2023-03-22 Health serious FDA
Health · FDA · Recall #FDA-D-0458-2023
Alprazolam Tablets, USP, 0.25mg, CIV, packaged in: a) 100-count bottle (NDC… Recall
Issued March 22, 2023 · Breckenridge Pharmaceutical, Inc
In March 2023, Breckenridge Pharmaceutical, Inc recalled the Alprazolam Tablets, USP, 0.25mg, CIV, packaged in: a) 100-count bottle (NDC…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
CGMP Deviations: Potential risk of Cross Contamination
What you should do
- 1 Stop using Alprazolam Tablets, USP, 0.25mg, CIV, packaged in: a) 100-count bottle (NDC… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Breckenridge Pharmaceutical, Inc to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Breckenridge Pharmaceutical, Inc
- Category
- Health
- Recall date
- March 22, 2023
- Units affected
- Not reported
- Sold at
- USA nationwide.
- Recall number
- FDA-D-0458-2023
- Made in
- United States
- Issuing agency
- FDA
In context
- Breckenridge Pharmaceutical, Inc has 6 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 903rd Health recall we've logged in 2023.